Regulations.gov document
Attachment 1 - RLNAD Package Insert RE Suitability Petition from Felix Pharmaceuticals…
Supporting & Related Material · FDA-2021-P-1175 · posted Oct 28, 2021
Key facts
| Document ID | FDA-2021-P-1175-0003 |
|---|---|
| Title | Attachment 1 - RLNAD Package Insert RE Suitability Petition from Felix Pharmaceuticals Pvt. Ltd. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2021-P-1175 |
| Posted | Oct 28, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: